AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — AGM Information 2021
Aug 25, 2021
61842_rns_2021-08-25_9ab5c5fb-198e-40b4-bd39-a3a7949f289a.pdf
AGM Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
August 25, 2021
The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051
Scrip Code: 541540
Scrip Code: SOLARA
Dear Sir / Madam,
Sub: Fourth Annual General Meeting of the Company and disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
We wish to inform you that the Fourth Annual General Meeting (“AGM”) of the Company was held on Wednesday, August 25, 2021 through Video Conferencing.
Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Thanking you,
Yours faithfully,
For Solara Active Pharma Sciences Limited
==> picture [146 x 39] intentionally omitted <==
S. Murali Krishna Company Secretary
Encl.: as above
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
SUMMARY OF PROCEEDINGS OF THE FOURTH ANNUAL GENERAL MEETING OF THE COMPANY HELD THROUGH VIDEO CONFERENCING ON WEDNESDAY, AUGUST 25, 2021 FROM 10:30 A.M TO 11:05 A.M.
Present:
Mr. Aditya Puri Non-Executive Director & Chairman Mr. Nirmal Bhogilal Independent Director Mr. R. Ramakrishnan Independent Director & Audit Committee Chairman Dr. Kausalya Santhanam Independent Director Mr. Kartheek Raju Non-Executive Director Mr. Rajender Rao Executive Director & Vice Chairman Mr. Bharath R Sesha Managing Director & CEO Mr. Subhash Anand Executive Director & CFO Mr. S. Murali Krishna Company Secretary Mr. Sathya Koushik Partner, M/s. Deloitte Haskins & Sells LLP, Chartered Accountants Statutory Auditors of the Company Mr. Nilesh Shah Partner, Nilesh Shah & Associates, Practising Company Secretary Scrutinizer for the Voting process Mr. A Mohan Kumar Secretarial Auditor
Mr. Aditya Puri, Chairman welcomed the Members to the Fourth Annual General Meeting (AGM) of the Company and introduced the Directors and other invitees present in the meeting to the Members. Company Secretary confirmed that the requisite quorum was present and requested Chairman to conduct the meeting. Chairman called the meeting to order.
The members were informed that the requisite Statutory Registers and other documents referred to in the Notice of the AGM were available for online inspection on request by the Members. Members who were present at the AGM and had not cast their votes electronically through remote e-voting were provided an opportunity to cast their votes through e-voting during the meeting.
Mr. Bharath R Sesha, Managing Director & CEO, delivered his speech.
Thereafter, Mr. Aditya Puri, Chairman, invited queries from the Members of the Company, which was responded by Mr. Bharath R Sesha.
With the consent of the Members present, the Notice convening the AGM, the Report of the Board of Directors and the accounts for the Financial Year ended March 31, 2021 were taken as read.
Mr. Murali Krishna, further informed that as per the provisions of the Companies Act, 2013 and SEBI Listing Regulations, the Company had provided remote e-voting facility to all the Members through CDSL E-Voting platform to vote on all the resolutions proposed to be passed at the Meeting.
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
The cut-off date for determining the members who are entitled to vote through e-voting facility as well as voting at the meeting was Friday, August 20, 2021. The e-voting period commenced on August 22, 2021 at 9.00 a.m. and ended on August 24, 2021 at 5.00 p.m.
The following items of business as per the Notice of AGM dated May 6, 2021 were transacted at the meeting:
| Item No. |
Description / Resolutions | Type of Resolution |
|---|---|---|
| Ordinary Business | ||
| 1 | Adoption of Audited Financial Statements for the Financial Year ended March 31,2021. |
Ordinary Resolution |
| 2 | Declaration of Final Dividend and confirmation of Interim Dividend for the Financial Year ended March 31,2021 |
Ordinary Resolution |
| 3 | Item Withdrawn | NA |
| 4 | Re-Appointment of Mr. Ankur Nand Thadani, retiring director, as a Non-Executive Director |
Ordinary Resolution |
| Special Business | ||
| 5 | Appointment of Mr. Bharath R Sesha as Managing Director and CEO |
Special Resolution |
| 6 | Appointment of Mr. Subhash Anand as Executive Director and CFO | Special Resolution |
| 7 | To ratify the remuneration payable to the Cost Auditor for the financialyear 2020-21 |
Ordinary Resolution |
| 8 | To obtain approval for Transactions/ Contracts/ Arrangements with Aurore Life Sciences Private Limited up to Rs. 400 Crores in each financialyear commencingfrom FY 2021-22 |
Ordinary Resolution |
| 9 | To obtain approval for Transactions/ Contracts/ Arrangements with Aurore Pharmaceuticals Private Limited up to Rs. 200 Crores in each financialyear commencingfrom FY 2021-22 |
Ordinary Resolution |
Mr. Murali Krishna, stated that the consolidated results of the voting would be declared along with the Scrutinizer’s Report to the Stock Exchanges where the shares of the Company are listed and posted on the Company’s website within two days.
Mr. Aditya Puri, Chairman, thanked the shareholders and concluded the meeting.
For Solara Active Pharma Sciences Limited
==> picture [145 x 39] intentionally omitted <==
S. Murali Krishna Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942